Clinical Trial Update: A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mRNA-3745 for Glycogen storage disease type I (Ia) is ongoing, with the study conducted by Moderna and currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type
• Glycogen Storage Disease Type Ia

Drugs mentioned

• mRNA-3745 (mRNA-3745)

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Glycogen Storage Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING